Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers N > Headlines for Neurocrine Biosciences, Inc. > News item |
Neurocrine reiterated by Merrill at neutral
Neurocrine Bioscience Inc. was reiterated by Merrill Lynch analyst Eric Ende at a neutral rating following second-quarter results. Neurocrine shares Thursday dropped $1.89, or 3.77%, to close at $48.28 on volume of 1,270,901 shares versus the three-month running average of 515,798 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.